Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer

BACKGROUND: Muscle-invasive bladder cancer (MIBC) develops lymph node (LN) metastasis or distant metastasis, leading to recurrence and poor prognosis. The five-year survival rate of MIBC with LN or distant metastasis is only 8.1%; therefore, there is an urgent need to identify reliable biomarkers fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yi, Huang, Siwei, Wang, Zhanwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373733/
https://www.ncbi.nlm.nih.gov/pubmed/37519798
http://dx.doi.org/10.3389/fonc.2023.1191398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373733/
https://www.ncbi.nlm.nih.gov/pubmed/37519798
http://dx.doi.org/10.3389/fonc.2023.1191398

Ejemplares similares